Concepedia

Sarah Oelsner

SO

Statistics

Publications

8

Citations

911

H-Index

8

Active since

2014

Affiliations

Frankfurt Cancer Institute(Current)

Georg Speyer Haus

Goethe University Frankfurt

Deutsches Konsortium für Translationale Krebsforschung

German Cancer Research Center

Sarah Oelsner is an author at Frankfurt Cancer Institute specializing in oncology, immunology, and natural killer cell biology.

Publications per year

2014–2019

8

Publications

8

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

Congcong Zhang, Pranav Oberoi, Sarah Oelsner et al. · Frontiers in Immunology · 2017 · 306 citations · Full text

, , +17

Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival

Sabrina Genßler, Michael C. Burger, Congcong Zhang et al. · OncoImmunology · 2015 · 189 citations · Full text

, , +17

Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma

Sarah Oelsner, Miriam E. Friede, Congcong Zhang et al. · Cytotherapy · 2016 · 187 citations

, , +13

Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth

Sarah Oelsner, Anja Waldmann, Arne Billmeier et al. · International Journal of Cancer · 2019 · 85 citations

, , +17

Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival

Sarah Oelsner, Juliane Wagner, Miriam E. Friede et al. · International Journal of Cancer · 2016 · 61 citations · Full text

, , +17

1–5 of 8